Neutralizing Monoclonal Antibodies Block Human Immunodeficiency Virus Type 1 Infection of Dendritic Cells and Transmission to T Cells

Prevention of the initial infection of mucosal dendritic cells (DC) and interruption of the subsequent transmission of HIV-1 from DC to T cells are likely to be important attributes of an effective human immunodeficiency virus type 1 (HIV-1) vaccine. While anti-HIV-1 neutralizing antibodies have bee...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Frankel, Sarah S., Steinman, Ralph M., Michael, Nelson L., Kim, Silvia Ratto, Bhardwaj, Nina, Pope, Melissa, Louder, Mark K., Ehrenberg, Philip K., Parren, Paul W. H. I., Burton, Dennis R., Katinger, Hermann, VanCott, Thomas C., Robb, Merlin L., Birx, Deborah L., Mascola, John R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 1998
Assuntos:
Viral Pathogenesis and Immunity
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC110490/
https://ncbi.nlm.nih.gov/pubmed/9811714
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados